EIF2AK3 and breast cancer: The most familiar small-molecule PERK inhibitor, GSK2606414, which is said to be the first one with high specificity for this kinase, was successfully tested on HT-29 colon cancer cell culture and proven to reduce breast cancer cells metastasis in vivo [281,282].